Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity
Open accessThe DOI matches its Crossref record; 68 of the 71 references it cites were found in a registry or an index.
Abstract
Recent genetic evidence supports a link between microglia and the complement system in Alzheimer's disease (AD). In this study, we uncovered a novel role for the microglial complement receptor 3 (CR3) in the regulation of soluble β-amyloid (Aβ) clearance independent of phagocytosis. Unexpectedly, ablation of CR3 in human amyloid precursor protein-transgenic mice results in decreased, rather than increased, Aβ accumulation. In line with these findings, cultured microglia lacking CR3 are more efficient than wild-type cells at degrading extracellular Aβ by secreting enzymatic factors, including tissue plasminogen activator. Furthermore, a small molecule modulator of CR3 reduces soluble Aβ levels and Aβ half-life in brain interstitial fluid (ISF), as measured by in vivo microdialysis. These results suggest that CR3 limits Aβ clearance from the ISF, illustrating a novel role for CR3 and microglia in brain Aβ metabolism and defining a potential new therapeutic target in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, fibrinogen/CD11b signaling may enhance Aβ-induced neurodegeneration by suppressing Aβ clearance (Czirr et al., 2017).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Czirr et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although CR3 mediates the clearance of fibrillar and oligomeric Aβ, it might also promote the accumulation of Aβ deposits [144, 145].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [144]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Further, studies manipulating the complement system have yielded mixed results.”
The cited source says what the claim attributes to it.
In the citing paper
“The deficiency of complement factors such as C1q, C3, C3ar1, C5aR, and Cd59, has exacerbated neuropathology in some studies [84–86] and reduced neuropathology in others [87–89].”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Aβ plaque burden was decreased in the hippocampus of 5XFAD:Fggγ390–396A mice (Figure 4B).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Czirr et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · cited 2×
“, 2012), as well as the removal of synapses during development (Stevens et al., 2007; Schafer et al., 2012), in a model of neurodegeneration (Stevens et al.”
BackgroundComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 3×
“, 2012), in a model of neurodegeneration (Stevens et al., 2007) and in amyloid precursor protein (APP)–transgenic mice (Hong et al.”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“…genetic support from genome-wide association studies that have identified several single nucleotide polymorphisms in immune-related genes that increase the risk of developing late onset AD (Lambert et al., 2009; Jun et al., 2010; Naj et al., 2011; Guerreiro et al., 2013; Jonsson et al., 2013).”
BackgroundVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 2×
“This notion has received genetic support from genome-wide association studies that have identified several single nucleotide polymorphisms in immune-related genes that increase the risk of developing late onset AD (Lambert et al., 2009; Jun et al., 2010; Naj et al., 2011; Guerreiro et al., 2013; Jonsson et al., 2013).”
BackgroundResultGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 2×
“This notion has received genetic support from genome-wide association studies that have identified several single nucleotide polymorphisms in immune-related genes that increase the risk of developing late onset AD (Lambert et al., 2009; Jun et al., 2010; Naj et al., 2011; Guerreiro et al., 2013; Jonsson et al., 2013).”
BackgroundResult
Cited by
Items 101–135 of 135
Duan, X., Wang, F., Liu, W., Xie, Y., Yang, M., Ping, Y., Pan, Y., Wei, Z., Li, H., Zhang, Q.-P., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13346-z · Cited by 5
“The activation state of microglia and the complement system may be related to changes in plasma Aβ levels [136], and some immune factors, such as pro-inflammatory cytokines TNF-α and interferon γ (IFN-γ), can induce the release of Aβ [137] and reduce the ability of microglia to degrade Aβ [138].”
Interplay Between Key Molecular Signaling Pathways and Immune Players Following Brain Irradiation
Richard, S. A. (2025) · Mediators of Inflammation · doi:10.1155/mi/8833271 · Cited by 2
Revisiting Functional Heterogeneity of Microglia and Astroglia
Kotova, M. M., Apukhtin, K. V., Nikitin, S. V., & Kalueff, A. V. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024060036 · Cited by 2
Determining Ligand Binding and Specificity Within the β2-Integrin Family with a Novel Assay Platform
Plüss, C. J., Leiggener, C., Nikci, E., Mancuso, R. V., Rabbani, S., Lamers, C., & Ricklin, D. (2025) · Biomolecules · doi:10.3390/biom15020238 · Cited by 2
“Interestingly, CR3 is involved in synaptic pruning and regulation of A β -induced neuroinflammation [30,31], and has been discussed as a prominent contributor to the development of neurological disorders, including schizophrenia and Alzheimer’s disease [32].”
Galectin-3 shapes microglial phenotype through endogenous and exogenous mechanisms
Camprubí-Ferrer, L., Yang, Y., Fernández‐Calle, R., Boza‐Serrano, A., García‐Revilla, J., Frontiñán-Rubio, J., & Deierborg, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1729776 · Cited by 3
Microglial ITAM & ITIM Signaling in Neurodegenerative Disease and Brain Aging
Mangalmurti, A., Bonheur, A., & Lukens, J. R. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169910 · Cited by 2
New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
Mandlik, D. S., Mandlik, S. K., & Choudhary, H. B. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230427100702 · Cited by 2
Youth-associated protein TIMP2 alters microglial state and function in the context of agingPreprint
Hemmer, B. M., Ferreira, A. C., Philippi, S. M., Petridis, S. F., Phan, A., & Castellano, J. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.20.655226 · Cited by 1
A neuron, microglia, and astrocyte triple coculture model to study Alzheimer diseasePreprint
Luchena, C., Zuazo-Ibarra, J., Valero, J., Matute, C., Alberdi, E. M., & Capetillo‐Zarate, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.13.472367
“The use of animal models of AD has demonstrated that targeting glial cells can ameliorate the disease progression (Furman et al., 2012; Czirr et al., 2017).”
BackgroundChernyaeva, L., Ratti, G., Teirilä, L., Rankka, U., Fudo, S., Pelkonen, A., Korhonen, P., Leskinen, K., Keskitalo, S., Salokas, K., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4163140
Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing
Camprubí-Ferrer, L., Soldán-Hidalgo, J., Axell, E., Dell’Eva, M., García-Cruzado, M., García‐Revilla, J., Yang, Y., Fernández‐Calle, R., Larlham, L., Chouhan, B., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1101/2025.03.17.643790 · Cited by 1
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26085212
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737959
Ehirchiou, D., Bernabei, I., Pandian, V. D., Nasi, S., Chobaz, V., Castelblanco, M., So, A., Martinon, F., Li, X., Acha‐Orbea, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26732293
Hou, L., Liu, J., Sun, F., Huang, R., Chang, R., Ruan, Z., Wang, Y., Zhao, J., & Wang, Q. (2023) · Figshare · doi:10.6084/m9.figshare.22603573
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737980
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737965
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737977
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737971
Additional file 1 of Modulation of C5a–C5aR1 signaling alters the dynamics of AD progression
Carvalho, K., Schartz, N. D., Balderrama-Gutierrez, G., Liang, H. Y., Chu, S.-H., Selvan, P., Gómez-Arboledas, Á., Petrisko, T. J., Fonseca, M. I., Mortazavi, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20296174
Zhang, D., Li, S., Hou, L., Lu, J., Ruan, Z., Peng, B., Zhang, X., Hong, J.-S., Zhao, J., & Wang, Q. (2021) · Figshare · doi:10.6084/m9.figshare.13525190
Ehirchiou, D., Bernabei, I., Pandian, V. D., Nasi, S., Chobaz, V., Castelblanco, M., So, A., Martinon, F., Li, X., Acha‐Orbea, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26019619
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737962
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26085125
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737974
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737983
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737956
Ehirchiou, D., Bernabei, I., Pandian, V. D., Nasi, S., Chobaz, V., Castelblanco, M., So, A. K. L., Martinon, F., Li, X., Acha‐Orbea, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26019692
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737968
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737986
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Xi, R., Zheng, X., Zhao, J., & Fu, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03819-x · Cited by 2
“Moreover, CR3 promotes the phagocytic clearance of fibrillar amyloid-β and inhibits the secretion of Aβ-degrading enzymes, thereby impairing proteolytic degradation [109, 110].”
Youth-associated protein TIMP2 regulates microglial state and function in healthy and aged mice
Hemmer, B. M., Philippi, S. M., Ferreira, A. C., Petridis, S. F., Phan, A., & Castellano, J. M. (2026) · Nature Communications · doi:10.1038/s41467-026-74906-z · Cited by 1
Wang, T., Wang, L., Cao, J., Zhao, Y., He, Z., & Lu, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1956600
“Cell-speci fi c experimental studies identify microglia as a major source of C1q and show that C1q recognition, C3 opsonization, CR3-dependent uptake, C5a signaling, and membrane-attack-complex formation can in fl uence clearance and tissue injury (134 – 136).”
Targeting the peripheral immune system for treatment of Alzheimer’s disease
Almasarani, E., Fog, M. H., Vorup‐Jensen, T., & Juul‐Madsen, K. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00054-9
“However, CR3 signaling can also limit enzymatic degradation of soluble Aβ, indicating that integrin-mediated clearance mechanisms depend strongly on the molecular form of Aβ and whether removal occurs via phagocytosis or extracellular degradation [164].”
Metadata
- Authors
- Czirr, E., Castello, N. A., Mosher, K. I., Castellano, J. M., Hinkson, I. V., Lucin, K. M., Baeza-Raja, B., Ryu, J. K., Li, L., Farina, S. N., Belichenko, N. P., Longo, F. M., Akassoglou, K., Britschgi, M., Cirrito, J. R., & Wyss-Coray, T.
- Affiliations
- Stanford Medicine (US)
- University of California, San Francisco (US)
- VA Palo Alto Health Care System (US)
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305 1
- Washington University in St. Louis (US)
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-03-15
- Volume
- 214
- Issue
- 4
- Pages
- 1081-1092
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5379986
- OpenAlex
- W2596986005
- Cited by
- 126
- References
- 71
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 26 · 2023: 20 · 2022: 9 · 2021: 16 · 2020: 17 · 2019: 9 · 2018: 7 · 2017: 5
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by-nc-sa)
- Funders
- Alexander von Humboldt Foundation
- Jane Coffin Childs Memorial Fund for Medical Research
- National Institute of Neurological Disorders and Stroke (P01 NS074969)
- National Institutes of Health
- National Institute on Aging (R01 AG042513, AG045034)
- Department of Veterans Affairs
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- microglia, complement receptor 3, CD11b/CD18, Alzheimer's disease, amyloid clearance, tissue plasminogen activator, proteolytic activity, amyloid precursor protein transgenic mice, brain interstitial fluid, complement system, small molecule modulators, therapeutic target
- MeSH terms
- Alzheimer Disease, Animals, Benzoates, Brain, Mice, Inbred C57BL, Thiohydantoins, Macrophage-1 Antigen, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.